February 07, 2025

24-Month Study Shows Ritlecitinib Efficacy in Alopecia

73.5% of patients achieved a SALT score ≤ 20 after 24 months of ritlecitinib treatment, according to new phase III findings.

Conexiant

April 26, 2024

Vladimir Botchkarev, MD, PhD, Honored With 2023 Skin Ageing & Challenges Best Scientific Award

Vladimir Botchkarev received the 2023 Skin Ageing & Challenges Best Scientific Award.

Conexiant

April 29, 2024

Identifying Common Triggers of Photocontact Dermatitis

Discover how exposure to certain fruits, vegetables, drugs, and plants can trigger symptoms of photocontact dermatitis and the importance of seeking shade and wearing protective clothing in the sun.

Conexiant

December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

April 30, 2024

AAD 2024: AAD Welcomes Seemal R. Desai, MD, FAAD, as President

Seemal R. Desai, MD, FAAD, began his 1-year term as President of the American Academy of Dermatology (AAD) as well as its sister association the AAD Association at the conclusion of the 2024 AAD Annual Meeting.

Conexiant

April 17, 2024

RP1 Immunotherapy in Solid Organ Transplant Recipients with Skin Cancer

A novel oncolytic immunotherapy using a modified herpes simplex virus has shown promise in treating skin cancers in solid organ transplant recipients, offering potential alternative treatment, revealed at the AACR Annual Meeting 2024.

Conexiant

May 21, 2024

Onychopapilloma May Be Linked to BAP1 Tumor Predisposition Syndrome

Researchers have discovered that the presence of a benign nail condition known as onychopapilloma may lead to the diagnosis of BAP1 tumor predisposition syndrome.

Conexiant

October 12, 2023

Nonmelanoma Skin Cancers May Have Higher Mortality Rate Than Melanoma

How do the mortality rates associated with nonmelanoma skin cancers and melanoma compare? A study presented at the recent European Academy of Dermatology and Venerology Congress 2023 investigated.

The ASCO Post

April 29, 2024

New Strategies to Manage and Minimize Exposure to HIV, Other STIs; Advance Gender-Affirming Care

New treatments for HIV and STIs in LGBTQ+ patients, including novel preventive measures and dermatological care for transgender and gender-diverse patients, are highlighted in a recent AAD press release.

Conexiant